Literature DB >> 12960839

Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.

Justin Stebbing1, Brian Gazzard, Ornella Flore, Claire Thomas, Adel Benlahrech, Sundhiya Mandalia, Mark Bower, Frances Gotch, Steve Patterson.   

Abstract

Although the innate immune system is implicated in the control of Kaposi's sarcoma (KS), the risk of developing KS is not associated with the nadir natural killer (NK) cell count, and NK cell counts do not significantly increase or decrease during KS resolution. KS-associated herpesvirus replication was not demonstrated in vivo or in vitro within NK cells, suggesting that NK cells do not contribute to the resolution of KS. Their role appears limited to events occurring during early infection.

Entities:  

Mesh:

Year:  2003        PMID: 12960839     DOI: 10.1097/01.aids.0000088168.01779.01

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  6 in total

1.  KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice.

Authors:  Christopher H Parsons; Laura A Adang; Jon Overdevest; Christine M O'Connor; J Robert Taylor; David Camerini; Dean H Kedes
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

2.  Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality.

Authors:  J Stebbing; M Bower; S Mandalia; M Nelson; B Gazzard
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.

Authors:  Martin R Goodier; C M Mela; A Steel; B Gazzard; M Bower; F Gotch
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

4.  Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma.

Authors:  Stéphanie Dupuy; Marion Lambert; David Zucman; Siméon-Pierre Choukem; Sara Tognarelli; Cécile Pages; Céleste Lebbé; Sophie Caillat-Zucman
Journal:  PLoS Pathog       Date:  2012-01-12       Impact factor: 6.823

5.  The host control of lytic and latent infection with human herpesvirus-8.

Authors:  Justin Stebbing; Brian Gazzard; Mark Bower
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

Review 6.  Prospects for NK Cell Therapy of Sarcoma.

Authors:  Mieszko Lachota; Marianna Vincenti; Magdalena Winiarska; Kjetil Boye; Radosław Zagożdżon; Karl-Johan Malmberg
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.